💪 Healthy ageing ingredients
Other news
Quick news
💉 GLP-1
Top news
<aside>
💊
Lembas emerged with $3.6M to develop GLP-1-boosting peptide for satiety
</aside>
- Lembas, an Israeli startup, emerged from stealth with $3.6M raised to develop its AI-designed bioactive peptide that triggers the production of GLP-1 and other gut hormones regulating appetite.
- The peptide binds multiple receptors and is encapsulated for slow release in the gut, showing satiety effects in preclinical models.
- Lembas plans to sell its peptide as a branded supplement or ingredient for bars, shakes, and snacks, targeting GRAS approval by end‑2026 and partnerships with major food and wellness companies.
Comment: this is one of the very first players publicly emerging with an ingredient that could be relatively soon available and integrated into food products seeking to act as GLP-1 alternatives or boosters.
**AgFunderNews & Lembas CEO’s LinkedIn**
Other news
<aside>
🧬
Amplifye unveils precision-fermented enzyme targeting digestion and blood glucose control
</aside>
- Amplifye, a US-based startup, launched “P24”, an enzyme produced through precision fermentation and designed to support protein digestion, blood glucose control, digestion comfort, and sleep.
- The enzyme is patented for blood glucose control and available as a supplement.
- A human clinical trial is planned to validate its claims, which were preliminarily demonstrated in lab studies showing improved protein digestibility and essential amino acid levels.
AgFunderNews